These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36155118)

  • 1. FDA validation of surrogate endpoints in oncology: 2005-2022.
    Walia A; Haslam A; Prasad V
    J Cancer Policy; 2022 Dec; 34():100364. PubMed ID: 36155118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?
    Kemp R; Prasad V
    BMC Med; 2017 Jul; 15(1):134. PubMed ID: 28728605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
    Wallach JD; Ciani O; Pease AM; Gonsalves GS; Krumholz HM; Taylor RS; Ross JS
    BMC Med; 2018 Mar; 16(1):45. PubMed ID: 29562926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.
    Pease AM; Krumholz HM; Downing NS; Aminawung JA; Shah ND; Ross JS
    BMJ; 2017 May; 357():j1680. PubMed ID: 28468750
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.
    Yu T; Hsu YJ; Fain KM; Boyd CM; Holbrook JT; Puhan MA
    BMJ Open; 2015 Nov; 5(11):e007960. PubMed ID: 26614616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials.
    Chen EY; Joshi SK; Tran A; Prasad V
    JAMA Intern Med; 2019 May; 179(5):642-647. PubMed ID: 30933235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate Endpoints in Pediatric Studies Submitted to the US FDA.
    Green DJ; Sun H; Burnham J; Liu XI; van den Anker J; Temeck J; Yao L; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2019 Mar; 105(3):555-557. PubMed ID: 30094815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration-approved solid tumor therapies, 1995-2021.
    Alabaku O; Laffey TN; Suh K; Li M
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1219-1223. PubMed ID: 36282934
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs.
    Kraus VB; Simon LS; Katz JN; Neogi T; Hunter D; Guermazi A; Karsdal MA
    Osteoarthritis Cartilage; 2019 Apr; 27(4):571-579. PubMed ID: 30465809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration.
    He Q; Li Q; Lv F; Kaitin KI; Shao L
    Ther Innov Regul Sci; 2021 Jul; 55(4):676-684. PubMed ID: 33683659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs.
    Gyawali B; Hey SP; Kesselheim AS
    EClinicalMedicine; 2020 Apr; 21():100332. PubMed ID: 32382717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.
    Downing NS; Aminawung JA; Shah ND; Krumholz HM; Ross JS
    JAMA; 2014 Jan 22-29; 311(4):368-77. PubMed ID: 24449315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review.
    Arciero V; Delos Santos S; Koshy L; Rahmadian A; Saluja R; Everest L; Parmar A; Chan KKW
    JAMA Netw Open; 2021 Feb; 4(2):e2033004. PubMed ID: 33570573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and outcome research in oncology. The need for integration.
    Apolone G
    Health Qual Life Outcomes; 2003 Apr; 1():3. PubMed ID: 12713667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated approval drug labels often lack information for clinical decision-making.
    Ballreich J; Socal M; Bennett CL; Xuan A; Trujillo A; Anderson G
    Pharmacotherapy; 2023 Apr; 43(4):300-304. PubMed ID: 36872463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014).
    Gnanasakthy A; DeMuro C; Clark M; Haydysch E; Ma E; Bonthapally V
    J Clin Oncol; 2016 Jun; 34(16):1928-34. PubMed ID: 27069082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meaningful endpoints for therapies approved for hematologic malignancies.
    Smith BD; DeZern AE; Bastian AW; Durie BGM
    Cancer; 2017 May; 123(10):1689-1694. PubMed ID: 28222220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
    Bast RC; Thigpen JT; Arbuck SG; Basen-Engquist K; Burke LB; Freedman R; Horning SJ; Ozols R; Rustin GJ; Spriggs D; Wenzel LB; Pazdur R
    Gynecol Oncol; 2007 Nov; 107(2):173-6. PubMed ID: 17950384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate.
    Chen EY; Raghunathan V; Prasad V
    JAMA Intern Med; 2019 Jul; 179(7):915-921. PubMed ID: 31135822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.